Amryt Pharma is quoted on the London Stock Exchange’s AIM Market and the Irish Stock Exchange’s Euronext Market.

Major Shareholders

Major shareholders

Major shareholders are as follows (interest as at 20 September 2019).

Name Number of shares % of issued share capital
Software AG-Stiftung 10,212,153 19.2%
Axa Investment Mgmt 4,490,061 8.4%
Raglan Road Capital 4,116,224 7.7%
Highbridge 3,673,094 6.9%
Joseph Wiley 3,499,081 6.6%
Legal & General 2,375,000 4.5%
Amati 2,200,980 4.1%
Rory Nealon 1,610,770 3.0%

There are a total of 53,149,070 shares in issue and no shares held in treasury. Pursuant to the AIM Rules, and insofar as the Company is aware, as at 30 August 2019, 31.5% of the Company’s AIM securities were not in public hands.

Restrictions: there are no restrictions on the transfer of Ordinary Shares.
Takeover Code: the Company is subject to the City Code on Takeovers and Mergers.